Alpha Diagnostics International Inc Company Profile

20:06 EDT 22nd September 2017 | BioPortfolio

Alpha Diagnostic International (ADI) located in San Antonio, Texas, USA, is a major provider of custom services such as peptides synthesis and polyclonal antibodies. ADI specializes in the development, manufacture, and distribution of variety of ELISA reagents and kits for animal and human research. ADI maintains an USDA inspected and approved, animal facility. We have introduced a number of specialized antibodies to a variety of new genes including obese/leptin, membrane receptors, and neurotransmitter transporters.


5415 Lost Lane
San Antonio
United States of America


Phone: (210) 561-9515
Fax: (210) 561-9544

News Articles [1748 Associated News Articles listed on BioPortfolio]

Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference

NESS ZIONA, Israel, May 24, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA.TA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that a ...

Kamada Ltd. Presents Updated Data From Phase II Clinical Trial Of Inhaled Alpha-1-Antitrypsin For Treatment Of Alpha-1 Antitrypsin Deficiency At 2017 American Thoracic Society International Conference

  Life Sciences Jobs   ...

Pharnext präsentiert auf der Alzheimer's Association International Conference 2017 Daten zu PXT864

Pflichtmitteilung: Pharnext SA (Paris:ALPHA) (FR00111911287 ALPHA), ein biopharmazeutisches Unternehmen und Vorreiter bei der Entwicklung von innovativen Arzneimitteln basierend auf der Kombinatio...

Pharnext Amends the Protocol of the International Pivotal Phase 3 Trials of PXT3003 for Charcot-Marie-Tooth Disease Type 1A

- No safety concern and PXT3003 development milestones remain unchanged - Regulatory News: Pharnext SA (Paris:ALPHA) (FR00111911287 ALPHA), a biopharmaceutical company pioneering a new approach to...

X-ray Study Explains How Takinib Inhibits TNF-alpha

Takinib, a selective TAK1 inhibiting drug, has been shown to broaden the therapeutic efficacy of TNF-alpha (Tumor necrosis factor-alpha) inhibition...

Co-Diagnostics, Synbiotics launch joint venture CoSara Diagnostics in India

Co-Diagnostics, a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced the recent incorporation of CoSara Diagnostics, a ...

Apic Bio seeded with $1mm

Gene therapy company Apic Bio Inc. spun off from the University of Massachusetts and was seeded with $1mm from the venture philanthropy arm of the Alpha-1 Foundation and private investor Ed Krapels, w...

StoneCalibre Affiliate Acquires In-Vitro Diagnostics Products Provider Alpha-Tec Systems

  Life Sciences Jobs   ...

PubMed Articles [2426 Associated PubMed Articles listed on BioPortfolio]

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.

In Alzheimer's disease (AD) research, both 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) positron emission tomography (PET) and electroencephalography (EEG) are reliable investigational modalities. The aim ...

Preparation and characterization of a human scFv against the Clostridium perfringens type A alpha-toxin.

Alpha-toxin produced by Clostridium perfringens is an important virulence factor, causing food poisoning and gas gangrene in humans. As such, it is considered a potential bioterrorism threat. To date,...

Prevalence of type I sensitization to alpha-gal in forest service employees and hunters.

The production of IgE molecules specific to the carbohydrate galactose-α-1,3-galactose (alpha-gal) is known to induce delayed anaphylaxis against mammalian meat. Tick bites constitute the primary sen...

SERPINA1 and MAN1B1 polymorphisms are not linked to severe liver disease in a French cohort of alpha 1-Antitrypsin deficiency children.

Fifteen to twenty percent of alpha-1 anti-trypsin deficiency patients (A1ATD) have a severe liver outcome (portal hypertension - PHT) during childhood. Since they all share the same ZZ SERPINA1 genoty...

Clinical Trials [1754 Associated Clinical Trials listed on BioPortfolio]

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

This is an evaluation of the effectiveness of darbepoetin alpha in treating anemia of MDS patients with an International Prognostic Scoring System (IPSS) score of low or intermediate 1.

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

Enhanced Diagnostics for Early Detection of Atrial Fibrillation - Prospective Validation

Prospective, blinded, multicenter international trial to test the Preventicus Heartbeats App in a prospective cohort.

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Companies [2218 Associated Companies listed on BioPortfolio]

Alpha Diagnostics International Inc

Alpha Diagnostic International (ADI) located in San Antonio, Texas, USA, is a major provider of custom services such as peptides synthesis and polyclonal antibodies. ADI specializes in the development...

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...


Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

More Information about "Alpha Diagnostics International Inc" on BioPortfolio

We have published hundreds of Alpha Diagnostics International Inc news stories on BioPortfolio along with dozens of Alpha Diagnostics International Inc Clinical Trials and PubMed Articles about Alpha Diagnostics International Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpha Diagnostics International Inc Companies in our database. You can also find out about relevant Alpha Diagnostics International Inc Drugs and Medications on this site too.

Quick Search

Relevant Topic

Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Corporate Database Quicklinks

Searches Linking to this Company Record